NEW YORK (GenomeWeb) – Wells Fargo Securities today downgraded shares of Agilent Technologies to Market Perform, saying the company's stock is already trading at a premium.

The investment bank also lowered the valuation range on Agilent's stock to between $41 and $43 from a previous range of $57 to $59.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.